Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin in cSSSI with Renal Impairment
NCT00102947Phase 4Terminated
- Sponsor
- Merck & Co.
- Start
- Jan 2005
- Primary completion
- Nov 2006
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daptomycin in Complicated skin and skin structure infection (cSSSI), sponsored by Merck & Co.. Started Jan 2005; status: terminated.
02
Drugs
daptomycin
03
Conditions
Complicated skin and skin structure infection (cSSSI)
Beyond the preview
Go deeper on NCT00102947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102947.